• 제목/요약/키워드: Stent-induced complication

검색결과 3건 처리시간 0.021초

Types of Thromboembolic Complications in Coil Embolization for Intracerebral Aneurysms and Management

  • Kim, Hong-Ki;Hwang, Sung-Kyun;Kim, Sung-Hak
    • Journal of Korean Neurosurgical Society
    • /
    • 제46권3호
    • /
    • pp.226-231
    • /
    • 2009
  • Objective : We describe our clinical experiences and outcomes in patients who had thromboembolic complications occurring during endovascular treatment of intracerebral aneurysms with a review of the literature. The types of thromboembolic complications were divided and the treatment modalities for each type were described. Methods : Between August 2004 and March 2009 we performed endovascular embolization with Guglielmi detachable coils for 173 patients with 189 cerebral aneurysms, including ruptured and unruptured aneurysms at our hospital. Sixty-eight patients were males and 105 patients were females. The age of patients ranged from 22-82 years (average, 58.8 years). We retrospectively evaluated this group with regard to complication rates and outcomes. The types of thromboembolic complications were classified into the following three categories: mechanical obstruction, distal embolic stroke, and stent-induced complications, which corresponded to types I, II, and III, respectively. A comparison of the clinical results was made for each type of complication. Results : Only eight patients had a thromboembolic complication during or after a procedure (4.6%). Of the eight patients, two had a mechanical obstruction as the causative factor; the other three patients had distal embolic stroke as the causative factor. The remaining three patients had stent-induced complications. In cases of mechanical obstruction, recanalization occurred due to the use of intra-arterial thrombolytic agents in one of two patients. Nevertheless, a poor prognosis was seen. In the cases of stent-induced complications, in one of three patients in whom a thrombus developed following stent insertion, a middle cerebral artery territory infarct developed with a poor prognosis despite the use of wiring and an intra-arterial thrombolytic agent. In the cases of distal embolic stroke, all three patients achieved good results following the use of antiplatelet agents. Conclusion : Treatment for thromboemboic complications due to mechanical obstruction and stent-induced complications include antiplatelet and intra-arterial thrombolytic agents; however, this cannot guarantee a sufficient extent of effectiveness. Therefore, active treatments, such as balloon angioplasty, stent insertion, and clot extraction, are helpful.

쥐 대장에서 스텐트 삽입 후 발생하는 조직 과증식 모델 형성을 위한 연구 (A Mouse Colon Model to Investigate Stent-Induced Tissue Hyperplasia)

  • 김민태
    • 한국방사선학회논문지
    • /
    • 제14권4호
    • /
    • pp.439-445
    • /
    • 2020
  • 본 연구는 쥐 대장 모델에서 자가팽창형 금속형 스텐트 삽입을 통한 삽입술의 유용성과 조직 과증식을 평가하고자 한다. 먼저 C57BL/6 쥐 대장의 직경을 확인하기 위해 1마리의 대장 투시조영 사전 실험을 실행하였다. 평균 직경은 4.05 mm였다. C57BL/6 쥐들은 두 군으로 나누어 각각 다른 스텐트의 직경을 비교 평가하였다. A 군은 직경이 5 mm, B군은 4mm 였다. 추적관찰 검사는 매주 투시를 통해 스텐트 삽입의 이상 유무를 평가하였다. 4주 후 내시경적 검사를 시행하고 희생하여 육안적 관찰 및 H&E 염색을 통해 조직 과증식을 평가하였다. 스텐트 삽입술은 시술 중 천공이 일어난 1마리를 제외하고 모든 쥐에서는 성공적으로 삽입되었다. 해당 데이터는 본 실험에서 제외하였다. 추적관찰 실험 기간에 A군에 속한 5마리의 쥐는 스텐트 삽입 후 7일 이내에 천공에 의해 사망하였다. B군의 1마리의 쥐는 곧창자로 스텐트의 이동이 발생하였다. A, B 군에서의 합병증은 각각 60%, 10%로 나타났다. 육안적 내시경적 결과에서는 모든 군에서 스텐트 와이어사이로 전체적인 조직 과증식이 일어남을 확인하였다. 조직병리에서의 결과 또한 두 군 사이의 통계적 차이는 유의하지 않게 조직 과증식이 일어났음을 확인할 수 있었다. 대장 스텐트의 삽입술은 기술적으로 유용하게 삽입이 가능했으며, 스텐트에 의한 조직 과증식이 쥐 모델에서 나타남을 확인하였다. 또한 스텐트 사이즈의 증가에 따라 쥐 대장내 천공이 많이 발생함을 확인할 수 있었다.

Recurrent Aortobronchial Fistula after Endovascular Stenting for Infected Pseudoaneurysm of the Proximal Descending Thoracic Aorta: Case Report

  • Lee, Sun-Geun;Lee, Seung Hyong;Park, Won Kyoun;Kim, Dae Hyun;Song, Jae Won;Cho, Sang-Ho
    • Journal of Chest Surgery
    • /
    • 제54권5호
    • /
    • pp.425-428
    • /
    • 2021
  • Aortobronchial fistula (ABF) induced by an infected pseudoaneurysm of the thoracic aorta is a life-threatening condition. As surgical treatment is associated with significant mortality and morbidity, thoracic endovascular aneurysm repair (TEVAR) may be an alternative for the treatment of ABF. However, the long-term durability of this intervention is largely unknown and the recurrence of ABF is a potential complication. We experienced a case of recurrent ABF after stent grafting as an early procedure for an infected pseudoaneurysm of the thoracic aorta. Remnant ABF, bronchial and/or aortic wall erosion, vasa vasorum connected with ABF, and recurrent local inflammation of the thin aortic wall around ABF might cause recurrent hemoptysis. As a result, we suggest that TEVAR should be considered as a bridge therapy for the initial treatment of ABF resulting from an infected pseudoaneurysm, and that several options, such as second-stage surgery, should be considered to prevent the recurrence of ABF.